Ceftazidime/Avibactam-Based Versus Polymyxin B-Based Therapeutic Regimens for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection in Critically Ill Patients: A Retrospective Cohort Study

INTRODUCTION: Considering the importance of ceftazidime/avibactam (CAZ/AVI) and polymyxin B (PMB) in treating carbapenem-resistant Klebsiella pneumoniae (CRKP) infection, it is essential to evaluate the efficacy and safety of these agents and provide appropriate medical advice to clinical specialist...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Guanhao, Cai, Jiaqi, Zhang, Liang, Chen, Dayu, Wang, Linyu, Qiu, Yusi, Deng, Han, Bai, Hao, Bian, Xiaolan, He, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618002/
https://www.ncbi.nlm.nih.gov/pubmed/35976531
http://dx.doi.org/10.1007/s40121-022-00682-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618002/
https://www.ncbi.nlm.nih.gov/pubmed/35976531
http://dx.doi.org/10.1007/s40121-022-00682-0

Ejemplares similares